EXTENSION TRIAL OF OXCARBAZEPINE IN PATIENTS W/ PARTIAL SEIZURES

奥卡西平在部分癫痫发作患者中的扩展试验

• 批准号: 6265424
• 负责人: STEVEN C. SCHACHTER
• 金额: $ 2.98万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6265424
• 关键词: anticonvulsants; brain disorder chemotherapy; clinical research; drug adverse effect; drug screening /evaluation; human subject; human therapy evaluation; oral administration; partial seizure

To provide continued treatment with oral oxcarbazepine (OXC) for patients who completed the trial with IV GP 47779, and to evaluate the long-term safety and tolerability of OXC therapy.

为了通过口服奥卡西平（OXC）提供持续治疗，以使用IV GP 47779完成试验的患者，并评估OXC治疗的长期安全性和耐受性。